Published in Ultrasonics on March 29, 2012
Passive imaging with pulsed ultrasound insonations. J Acoust Soc Am (2012) 1.26
Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents. Ultrasound Med Biol (2013) 0.94
Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom. Ultrasound Med Biol (2012) 0.93
Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes. Mol Pharm (2012) 0.90
Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells. Biomaterials (2014) 0.86
Determination of the interfacial rheological properties of a poly(DL-lactic acid)-encapsulated contrast agent using in vitro attenuation and scattering. Ultrasound Med Biol (2013) 0.79
Impulse response method for characterization of echogenic liposomes. J Acoust Soc Am (2015) 0.78
Polymer-coated echogenic lipid nanoparticles with dual release triggers. Biomacromolecules (2013) 0.78
pH-triggered echogenicity and contents release from liposomes. Mol Pharm (2014) 0.76
Lipid Coated Microbubbles and Low Intensity Pulsed Ultrasound Enhance Chondrogenesis of Human Mesenchymal Stem Cells in 3D Printed Scaffolds. Sci Rep (2016) 0.75
Preparation and Characterization of Three Tilmicosin-loaded Lipid Nanoparticles: Physicochemical Properties and in-vitro Antibacterial Activities. Iran J Pharm Res (2016) 0.75
Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov (2005) 10.97
Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol (1965) 7.58
Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng (2007) 5.82
Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther (2007) 5.79
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res (2003) 3.89
Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov (2004) 3.09
Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev (2004) 2.73
Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol (2004) 2.45
Trends and developments in liposome drug delivery systems. J Pharm Sci (2001) 2.06
Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology (2007) 1.86
Characterization of ultrasound contrast microbubbles using in vitro experiments and viscous and viscoelastic interface models for encapsulation. J Acoust Soc Am (2005) 1.76
Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release (2006) 1.70
Subharmonic imaging of contrast agents. Ultrasonics (2000) 1.63
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol (2005) 1.61
Ultrasound contrast imaging: current and new potential methods. Ultrasound Med Biol (2000) 1.59
Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev (2008) 1.57
Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta (2004) 1.56
Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev (2008) 1.52
Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci (1996) 1.46
Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res (2006) 1.45
Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release (2006) 1.44
Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. J Pharm Sci (2001) 1.42
Attenuation and size distribution measurements of Definity and manipulated Definity populations. Ultrasound Med Biol (2007) 1.41
Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol (2007) 1.35
Advantages of subharmonic over second harmonic backscatter for contrast-to-tissue echo enhancement. Ultrasound Med Biol (1998) 1.31
Nondestructive subharmonic imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2002) 1.31
Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol (2002) 1.29
Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm (2005) 1.23
Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release (2010) 1.19
Subharmonic imaging with microbubble contrast agents: initial results. Ultrason Imaging (1999) 1.17
In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz. Ultrasound Med Biol (2004) 1.13
Ultrasonic characterization of the nonlinear properties of contrast microbubbles. Ultrasound Med Biol (2000) 1.12
Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. J Am Coll Cardiol (2009) 1.10
Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes. J Ultrasound Med (2008) 1.09
A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery. Ultrasound Med Biol (2008) 1.09
Transfection effect of microbubbles on cells in superposed ultrasound waves and behavior of cavitation bubble. Ultrasound Med Biol (2006) 1.08
The application of microbubbles for targeted drug delivery. Expert Opin Drug Deliv (2007) 1.07
Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J Pharm Sci (2008) 1.07
Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter. J Acoust Soc Am (2011) 1.06
In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes. Circulation (2010) 1.05
Subharmonic backscattering from ultrasound contrast agents. J Acoust Soc Am (1999) 1.01
Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents. Cell Mol Biol Lett (2002) 0.99
Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol (2010) 0.98
Material characterization of the encapsulation of an ultrasound contrast microbubble and its subharmonic response: strain-softening interfacial elasticity model. J Acoust Soc Am (2010) 0.97
The role of cavitation microjets in the therapeutic applications of ultrasound. Ultrasound Med Biol (2004) 0.94
Subharmonic signal generation from contrast agents in simulated neovessels. Ultrasound Med Biol (2004) 0.93
Microscopy imaging of liposomes: from coverslips to environmental SEM. Int J Pharm (2010) 0.92
Subharmonic generation from ultrasonic contrast agents. Phys Med Biol (1999) 0.88
Imaging technologies and techniques. Cardiol Clin (2004) 0.86
Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo. J Liposome Res (2010) 0.86
Gas-filled liposomes as echocardiographic contrast agents in rabbits with myocardial infarcts. Invest Radiol (1993) 0.79
A Newtonian rheological model for the interface of microbubble contrast agents. Ultrasound Med Biol (2003) 1.62
Advances in biomarker research for pancreatic cancer. Curr Pharm Des (2012) 1.05
Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II. J Am Chem Soc (2004) 1.05
On the suitability of broadband attenuation measurement for characterizing contrast microbubbles. Ultrasound Med Biol (2005) 1.04
Matrix metalloproteinase-assisted triggered release of liposomal contents. Bioconjug Chem (2007) 1.02
Characterization of novel radicals from COX-catalyzed arachidonic acid peroxidation. Free Radic Biol Med (2009) 1.01
Effects of encapsulation elasticity on the stability of an encapsulated microbubble. J Colloid Interface Sci (2009) 1.00
Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity. J Am Chem Soc (2006) 1.00
Material characterization of the encapsulation of an ultrasound contrast microbubble and its subharmonic response: strain-softening interfacial elasticity model. J Acoust Soc Am (2010) 0.97
Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II. J Am Chem Soc (2007) 0.96
Modeling subharmonic response from contrast microbubbles as a function of ambient static pressure. J Acoust Soc Am (2011) 0.94
Excitation threshold for subharmonic generation from contrast microbubbles. J Acoust Soc Am (2011) 0.94
Release of liposomal contents by cell-secreted matrix metalloproteinase-9. Bioconjug Chem (2009) 0.93
Stability analysis of an encapsulated microbubble against gas diffusion. J Colloid Interface Sci (2009) 0.93
Synthesis of barbiturate-based methionine aminopeptidase-1 inhibitors. Bioorg Med Chem Lett (2008) 0.91
Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9. J Am Chem Soc (2008) 0.91
Design of photocleavable lipids and their application in liposomal "uncorking". Chem Commun (Camb) (2005) 0.91
Bioactivity in in situ hydroxyapatite-polycaprolactone composites. J Biomed Mater Res A (2006) 0.91
Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes. Mol Pharm (2012) 0.90
Biodegradability enhancement of purified terephthalic acid wastewater by coagulation-flocculation process as pretreatment. J Hazard Mater (2007) 0.90
Formulation of photocleavable liposomes and the mechanism of their content release. Org Biomol Chem (2006) 0.89
New fluorescent probes for carbonic anhydrases. Chem Commun (Camb) (2007) 0.87
A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications. Biochim Biophys Acta (2013) 0.86
Fluorescent water soluble polymers for isozyme-selective interactions with matrix metalloproteinase-9. Bioorg Med Chem Lett (2011) 0.86
Spacer-based selectivity in the binding of "two-prong" ligands to recombinant human carbonic anhydrase I. Biochemistry (2005) 0.85
Characterization of free radicals formed from COX-catalyzed DGLA peroxidation. Free Radic Biol Med (2011) 0.85
Differentiation of prostate cancer cells using flexible fluorescent polymers. Anal Chem (2011) 0.85
Fluorescent liposomes for differential interactions with glycosaminoglycans. Anal Chem (2011) 0.83
Molecular basis for the origin of differential spectral and binding profiles of dansylamide with human carbonic anhydrase I and II. Biochemistry (2005) 0.83
"Uncorking" of liposomes by matrix metalloproteinase-9. Chem Commun (Camb) (2005) 0.82
A strategy for designing "multi-prong" enzyme inhibitors by incorporating selective ligands to the liposomal surface. Chem Commun (Camb) (2007) 0.81
Intrinsic selectivity in binding of matrix metalloproteinase-7 to differently charged lipid membranes. FEBS Lett (2007) 0.81
Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer. Mol Pharm (2014) 0.81
Start-up and stabilization of an Anammox process from a non-acclimatized sludge in CSTR. J Ind Microbiol Biotechnol (2010) 0.81
Inhibition of matrix metalloproteinase-9 by "multi-prong" surface binding groups. Chem Commun (Camb) (2005) 0.80
Two-prong inhibitors for human carbonic anhydrase II. J Am Chem Soc (2004) 0.80
Stability and microbial community structure of a partial nitrifying fixed-film bioreactor in long run. Bioresour Technol (2010) 0.80
Determination of the interfacial rheological properties of a poly(DL-lactic acid)-encapsulated contrast agent using in vitro attenuation and scattering. Ultrasound Med Biol (2013) 0.79
Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef. Biosens Bioelectron (2010) 0.79
Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors. Bioorg Med Chem Lett (2008) 0.79
Synthesis of metal-chelating lipids to sensitize lanthanide ions. J Org Chem (2003) 0.79
Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a. Biochemistry (2013) 0.78
Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9. Chem Commun (Camb) (2010) 0.78
Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme. Biochemistry (2014) 0.78
Energetic rationale for an unexpected and abrupt reversal of guanidinium chloride-induced unfolding of peptide deformylase. Protein Sci (2007) 0.78
Polymer-coated echogenic lipid nanoparticles with dual release triggers. Biomacromolecules (2013) 0.78
Microwave-assisted synthesis of triple-helical, collagen-mimetic lipopeptides. Nat Protoc (2009) 0.78
Kinetic study approach of remazol black-B use for the development of two-stage anoxic-oxic reactor for decolorization/biodegradation of azo dyes by activated bacterial consortium. J Hazard Mater (2008) 0.78
Nature of water in nacre: a 2D Fourier transform infrared spectroscopic study. Spectrochim Acta A Mol Biomol Spectrosc (2006) 0.77
Use of unnatural amino acids for design of novel organomodified clays as components of nanocomposite biomaterials. Philos Trans A Math Phys Eng Sci (2010) 0.77
Conjugation of poor inhibitors with surface binding groups: a strategy to improve inhibition. Chem Commun (Camb) (2003) 0.77
Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation. J Negat Results Biomed (2014) 0.77
Polymersome-based drug-delivery strategies for cancer therapeutics. Ther Deliv (2015) 0.77
Alkalinity and dissolved oxygen as controlling parameters for ammonia removal through partial nitritation and ANAMMOX in a single-stage bioreactor. J Ind Microbiol Biotechnol (2010) 0.77
Purification of recombinant human carbonic anhydrase-II by metal affinity chromatography without incorporating histidine tags. Protein Expr Purif (2004) 0.77
Thermodynamic studies on the recognition of flexible peptides by transition-metal complexes. Inorg Chem (2002) 0.77
pH-triggered echogenicity and contents release from liposomes. Mol Pharm (2014) 0.76
Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids. Bioconjug Chem (2016) 0.76
Effects of encapsulation damping on the excitation threshold for subharmonic generation from contrast microbubbles. J Acoust Soc Am (2012) 0.76
Experimental investigation of interfaces in hydroxyapatite/polyacrylic acid/polycaprolactone composites using photoacoustic FTIR spectroscopy. J Biomed Mater Res A (2006) 0.76
Synthesis of New Polymerizable Metal-Chelating Lipids. J Org Chem (1999) 0.76
Linker-induced anomalous emission of organic-molecule conjugated metal-oxide nanoparticles. ACS Nano (2012) 0.76
Polymeric nanoparticles with sequential and multiple FRET cascade mechanisms for multicolor and multiplexed imaging. Small (2013) 0.76
Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors. Mol Pharm (2017) 0.75
Fluorescent polymer-based post-translational differentiation and subtyping of breast cancer cells. Analyst (2012) 0.75
Hexanoic acid and polyethylene glycol double grafted amphiphilic chitosan for enhanced gene delivery: influence of hydrophobic and hydrophilic substitution degree. Mol Pharm (2014) 0.75
Glycosaminoglycan-mediated selective changes in the aggregation states, zeta potentials, and intrinsic stability of liposomes. Langmuir (2012) 0.75
Synthesis of new, pyrene-containing, metal-chelating lipids and sensing of cupric ions. Org Lett (2003) 0.75
An investigation on the analytical potential of polymerized liposomes bound to lanthanide ions for protein analysis. J Am Chem Soc (2004) 0.75
Lateral migration of a viscoelastic drop in a Newtonian fluid in a shear flow near a wall. Phys Fluids (1994) (2014) 0.75
Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I. Biochim Biophys Acta (2010) 0.75
Stable performance of non-aerated two-stage partial nitritation/anammox (PANAM) with minimal process control. Microb Biotechnol (2012) 0.75
Evaluation of two lanthanide complexes for qualitative and quantitative analysis of target proteins via partial least squares analysis. Anal Biochem (2005) 0.75
Solid-supported synthesis of polymerizable lanthanide-ion chelating lipids for protein detection. Inorg Chem (2005) 0.75
Intermittent cyclic process for enhanced biological nutrient removal treating combined chemical laboratory wastewater. Bioresour Technol (2006) 0.75
Feasibility of bioengineered two-stages sequential batch reactor and filtration-adsorption process for complex agrochemical effluent. Bioresour Technol (2013) 0.75
FAHP ranking and selection of pretreatment module for membrane separation processes in textile cluster. Bioresour Technol (2010) 0.75
Effects of entrapment on nucleic acid content, cell morphology, cell surface property, and stress of pure cultures commonly found in biological wastewater treatment. Appl Microbiol Biotechnol (2011) 0.75
Partial filling multiple injection affinity capillary electrophoresis (PFMIACE) to estimate binding constants of receptors to ligands. Talanta (2006) 0.75
Negative normal stress elasticity of emulsions of viscous drops at finite inertia. Phys Rev Lett (2005) 0.75
Artificial neural networks for qualitative and quantitative analysis of target proteins with polymerized liposome vesicles. Anal Biochem (2006) 0.75
Novel two stage bio-oxidation and chlorination process for high strength hazardous coal carbonization effluent. J Hazard Mater (2011) 0.75
Photoacoustic FTIR spectroscopic study of undisturbed nacre from red abalone. Spectrochim Acta A Mol Biomol Spectrosc (2005) 0.75
Correlating on-line monitoring parameters, pH, DO and ORP with nutrient removal in an intermittent cyclic process bioreactor system. Bioresour Technol (2008) 0.75
Recognition of isozymes via lanthanide ion incorporated polymerized liposomes. Chem Commun (Camb) (2007) 0.75